Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020473 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Monia Anania und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), 90146 Palermo, Italy. Hauptthemen laut MEDLINE: alpha-Galactosidase, Fabry Disease, Mutation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Anderson–Fabry disease is a hereditary, progressive, multisystemic lysosomal storage disorder caused by a functional deficiency of the enzyme α-galactosidase A (α-GalA). This defect is due to mutations in the GLA gene, located in the long arm of the X chromosome (Xq21-22). Functional deficiency of the α-GalA enzyme leads to reduced degradation and accumulation of its substrates, predominantly globotriaosylceramide (Gb3), which accumulate in the lysosomes of numerous cell types, giving rise to the symptomatology. Clinical diagnosis can still be difficult today due to the peculiarities of the disease, which presents with clinical manifestations that overlap with those of other pathologies and a wide possibility of differential diagnoses, which lead to missed diagnoses, misdiagnosis, or a diagnostic delay. Patients with clinical suspicion of Fabry disease undergo a diagnostic workup that includes an evaluation of α-GALA enzyme activity, genetic analysis of the GLA gene, and the measurement of blood Lyso-Gb3, a soluble derivative of Gb3. In this paper, we describe four novel mutations identified in the GLA gene which are associated with absent or reduced α-GalA activity, pathological accumulation of the specific substrate, and characteristic clinical manifestations of Fabry disease. We identified two mutations (c.583insGAATA and p.Y207X) that result in the formation of a premature translation stop codon, resulting in a truncated protein and thus a completely non-functional enzyme. The other two identified gene alterations (p.G261C and c.786G>T, which determine p.W262C) are missense mutations that cause reduced α-GALA activity, the accumulation of blood Lyso-Gb3, and symptoms consistent with Fabry disease, and therefore may be associated with this disorder. The identification of these new mutations in patients with symptoms attributable to Fabry disease increases the molecular knowledge of the GLA gene and provides important support to the clinician, for a more accurate and timely diagnosis of the pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), 90146 Palermo, Italy.
- Nephrology Unit, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
- School of Medicine and Surgery, University of Milano-Bicocca, 20126 Milan, Italy.
- Excellence Department of Health Promotion, Maternal and Child, Internal and Specialist Medicine "G. D'Alessandro", University of Palermo, 90127 Palermo, Italy.
- Internal Medicine, Ospedale Cattinara, 34149 Trieste, Italy.
ORCID-Profile: Paolo Colomba
Zitieren
APA
Anania, M., Pieruzzi, F., Giacalone, I., Trezzi, B., Marsana, E. M., Roggero, L., Francofonte, D., Stefanoni, M., Vinci, M., Zizzo, C., Zora, M., Di Chiara, T., Duro, G., Duro, G., & Colomba, P. (2025). Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020473
Vancouver
Anania M, Pieruzzi F, Giacalone I, Trezzi B, Marsana EM, Roggero L, et al. Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020473
BibTeX
@article{Anania2025,
author = {Anania, Monia and Pieruzzi, Federico and Giacalone, Irene and Trezzi, Barbara and Marsana, Emanuela Maria and Roggero, Letizia and Francofonte, Daniele and Stefanoni, Michele and Vinci, Martina and Zizzo, Carmela and Zora, Marcomaria and Di Chiara, Tiziana and Duro, Giulia and Duro, Giovanni and Colomba, Paolo},
title = {Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020473}
}
EUVIMED